Why the study?
Does pharmacokinetics-based dosing of VWF/FVIII concentrate improve clinical management in patients with acquired von Willebrand syndrome undergoing surgery?
Population
Patient with acquired von Willebrand syndrome (AVWS) undergoing surgery
Design
Case_report
Authors
Loading...
May support PK-guided dosing in AVWS surgery; hypothesis-generating and requires prospective validation.
Does pharmacokinetics-based dosing of VWF/FVIII concentrate improve clinical management in patients with acquired von Willebrand syndrome undergoing surgery?
Pharmacokinetics-based dosing of VWF/FVIII concentrate may optimize treatment and avoid unnecessary infusions in patients with acquired von Willebrand syndrome undergoing surgery.
Baldeo et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: